Myoblast transplantation for heart failure: Where are we heading?

Italian Heart Journal

Volumn 6, Issue 4, 2005, Pages 284-288

  Alfieri, Ottavio ^a   Livi, Ugolino ^b   Martinelli, Luigi ^c   Arpesella, Giorgio ^d   Valfrè, Carlo ^e   Lapenna, Elisabetta ^a   Desnos, Michel ^f   Hagège, Albert A ^f   Menasché, Philippe ^f  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e OSPEDALE CA FONCELLO   (Italy)

^f HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; CELL TRANSPLANTATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; DISEASE MODEL; EDITORIAL; FORECASTING; GRAFT REJECTION; GRAFT SURVIVAL; HOSPITALIZATION; HUMAN; MORTALITY; MYOBLAST; PROGNOSIS; RISK ASSESSMENT; STANDARD; SURVIVAL RATE; TRANSPLANTATION;

ANIMALS; CELL TRANSPLANTATION; CLINICAL TRIALS; DISEASE MODELS, ANIMAL; FORECASTING; GRAFT REJECTION; GRAFT SURVIVAL; HEART FAILURE, CONGESTIVE; HUMANS; MYOBLASTS; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE;

EID: 23044457935     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (27)

1. Jessup M, Brozena S. Heart failure. N Engl J Med 2003; 348: 2007-18.
2. Melo LG, Pachori AS, Kong D, et al. Molecular and cell-based therapies for protection, rescue, and repair of ischemic myocardium: reasons for cautious optimism. Circulation 2004; 109: 2386-93.
3. Li RK, Jia ZQ, Weisel RD, et al. Cardiomyocyte transplantation improves heart function. Ann Thorac Surg 1996; 62: 654-61.
4. Müller-Ehmsen J, Peterson KL, Kedes L, et al. Rebuilding a damaged heart: long-term survival of transplanted neonatal rat cardiomyocytes after myocardial infarction and effect on cardiac function. Circulation 2002; 105: 1720-6.
5. Dowell J, Rubart M, Pasumarthi KB, Soonpaa MH, Field LJ. Myocyte and myogenic stem cell transplantation in the heart. Cardiovasc Res 2003; 58: 336-50.
6. Al Attar N, Carrion C, Ghostine S, et al. Long-term (1 year) functional and histological results of autologous skeletal muscle cells transplantation in rat. Cardiovasc Res 2003; 58: 142-8.
7. Murry CE, Soonpaa MH, Reinecke H, et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004; 428: 664-8.
8. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004; 428: 668-73.
9. Thomson RB, Emani SM, Davis BH, et al. Comparison of intracardiac cell transplantation: autologous skeletal myoblasts versus bone marrow cells. Circulation 2003; 108 (Suppl 1): II264-II271.
10. Kinnaird T, Stabile E, Burnett MS, et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 2004; 94: 678-85.
11. Mathur A, Martin JF. Stem cells and repair of the heart. Lancet 2004; 364: 183-92.
12. Ghostine S, Carrion C, Souza LC, et al. Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction. Circulation 2002; 106 (Suppl I): I131-I136.
13. Leobon B, Garcin I, Menasche P, Vilquin JT, Audinat E, Charpak S. Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci USA 2003; 100: 7808-11.
14. Reinecke H, Minami E, Poppa V, Murry CE. Evidence for fusion between cardiac and skeletal muscle cells. Circ Res 2004; 94: E56-E60.
15. Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003; 114: 763-76.
16. Murtuza B, Suzuki K, Bou-Gharios G, et al. Transplantation of skeletal myoblasts secreting an IL-1 inhibitor modulates adverse remodeling in infarcted murine myocardium. Proc Natl Acad Sci USA 2004; 101: 4216-21.
17. Menasche P, Hagege AA, Scorsin M, et al. Myoblast transplantation for heart failure. Lancet 2001; 357: 279-80.
18. Menasche P, Hagege AA, Vilquin JT, et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 2003; 41: 1078-83.
19. Herreros J, Prosper F, Perez A, et al. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur Heart J 2003; 24: 2012-20.
20. Siminiak T, Kalawski R, Fiszer D, et al. Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up. Am Heart J 2004; 148: 531-7.
21. Dib N, McCarthy P, Dinsmore J, et al. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: interim analysis from the United States experience. (abstr) Circulation 2002; 106 (Suppl II): II-463.
22. Smits PC, van Geuns RJ, Poldermans D, et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. J Am Coll Cardiol 2003; 42: 2063-9.
23. Siminiak T, Fiszer D, Jerykcwska O, et al. Percutaneous transvenous transplantation of autologous myoblasts in the treatment of postinfarction heart failure - the POZNAN trial. (abstr) Eur Heart J 2004; 25 (Suppl): 264.
24. Hagege AA, Carrion C, Menasche P, et al. Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Lancet 2003; 361: 491-2.
25. Pagani FD, DerSimonian H, Zawadzka A, et al. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J Am Coll Cardiol 2003; 41: 879-88.
26. Moss AJ, Zareba W, Hall J, et al, for the Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-83.
27. Zhang M, Methot D, Poppa V, Fujio Y, Walsh K, Murry CE. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol 2001; 33: 907-21.